[
    {
        "utterance": "Shwetadwip Chowdhury: anyone you can either log in and write it yourself or you can tell me what to write in. I took a few notes while we were talking, but I don't think that I have nearly a comprehensive list. ",
        "annotations": {
            "identify gap": "The speaker mentions not having a comprehensive list, indicating a gap in their documentation.",
            "encourage participation": "The speaker is offering options for others to contribute ('you can either... or you can tell me').",
            "process management": "The speaker is managing how the note-taking process will work.",
            "assign task": "The speaker is essentially assigning the task of note-taking or providing information for note-taking."
        }
    },
    {
        "utterance": "Brian Pogue: Is there sort of a higher or super structure to what we discussed? ",
        "annotations": {
            "ask question": "The utterance is a direct request for information or clarification from previous discussions, fitting the definition of asking a question."
        }
    },
    {
        "utterance": "Ping Wang: Excuse me, can you add my name? I mean, I'm sorry. ",
        "annotations": {
            "ask question": "The speaker is requesting an action (adding their name) and possibly clarification or confirmation."
        }
    },
    {
        "utterance": "Brian Pogue: Yeah, I think. ",
        "annotations": {
            "Supportive response": "This code applies because the utterance 'Yeah, I think.' expresses agreement or validation for a previous statement without adding new content."
        }
    },
    {
        "utterance": "Ping Wang: I don't have access to the slide. I don't know. I couldn't find it from the Google Doc. ",
        "annotations": {
            "identify gap": "The speaker explicitly recognizes their lack of access to a resource (the slide) and their inability to find it in the Google Doc.",
            "ask question": "The utterance indirectly requests help or clarification on how to access the slide or information about its location."
        }
    },
    {
        "utterance": "Shwetadwip Chowdhury: Uh, why don't I just put this in the chat and maybe you can um. ",
        "annotations": {
            "process management": "The speaker is suggesting a method for sharing information in the chat, which relates to managing the flow of the meeting or organizing group activities."
        }
    },
    {
        "utterance": "Ping Wang: Okay. Oh, somebody already did it. Somebody already did it. There you go. ",
        "annotations": {
            "acknowledge contribution": "The speaker acknowledges that another group member has already taken care of an action item.",
            "supportive response": "The speaker expresses validation that an issue is resolved, showing a positive evaluation."
        }
    },
    {
        "utterance": "Brad Smith: Well, I think the first point here might be that this problem gets a lot harder as you get further up the chain, you know, so so obviously it on mono layers or cultures or even as we've learned from Crystal embryos, but then once you start getting to an immune system, you're in trouble. ",
        "annotations": {
            "develop idea": "The speaker is expanding on an existing topic by providing examples and explanations, elaborating on an existing idea."
        }
    },
    {
        "utterance": "Brad Smith: And that's something maybe I hadn't appreciated. There's definitely threshold points where this problem gets a lot harder a lot quickly. ",
        "annotations": {
            "develop idea": "The speaker is expanding on a thought or idea previously mentioned, providing further insight or clarification.",
            "identify gap": "The speaker mentions something they hadn't appreciated, indicating a recognition of their own lack of understanding or appreciation of a concept before."
        }
    },
    {
        "utterance": "Crystal Rogers: I would say the issue here is yeah, scale, time, and then complexity. ",
        "annotations": {
            "develop idea": "Crystal Rogers is expanding on existing ideas by specifying scale, time, and complexity as key issues.",
            "identify gap": "Crystal Rogers implicitly points to gaps or challenges related to scale, time, and complexity."
        }
    },
    {
        "utterance": "Shwetadwip Chowdhury: Uh, time meaning acquisition time or what? ",
        "annotations": {
            "ask question": "The speaker is seeking clarification on what was meant by 'time' in a previous statement, indicating a request for information."
        }
    },
    {
        "utterance": "Crystal Rogers: Well, that that's relevant too, but no, I actually meant um well, yeah, I guess that's relevant acquisition time, but also the amount of time that it takes between when you give the epitope or the treatment or the marker and the time that you're then going to image it whether or not that gets diluted or lost or attacked. So there's two different time issues. ",
        "annotations": {
            "develop idea": "Crystal Rogers is expanding on her previous idea, providing more details about the time issues involved in their research, specifically differentiating between acquisition time and the time between administration and imaging."
        }
    },
    {
        "utterance": "Shwetadwip Chowdhury: Uh, what's up? ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Shwetadwip Chowdhury: Uh, to dimensional imaging. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Allison Dennis: You're definitely going to have to economize on words though here. ",
        "annotations": {
            "offer feedback": "Provides a suggestion for improvement, which is to economize on words.",
            "process management": "Manages the meeting flow by suggesting efficiency in communication."
        }
    },
    {
        "utterance": "Brian Pogue: Right. ",
        "annotations": {
            "supportive response": "The utterance expresses agreement or validation without adding new content."
        }
    },
    {
        "utterance": "Brian Pogue: Or I could. ",
        "annotations": {
            "supportive response": "Brian Pogue is offering to take on a task, which can be seen as a supportive action to the group.",
            "None": "No other code seems to directly apply as Brian is not introducing a new idea, asking a question, or explicitly signaling expertise, but 'supportive response' captures his offer to contribute."
        }
    },
    {
        "utterance": "Shwetadwip Chowdhury: Just decrease it. ",
        "annotations": {
            "offer feedback": "This code applies because the utterance 'Just decrease it.' provides a specific suggestion for improvement or modification, presumably in response to a practical issue discussed in the conversation."
        }
    },
    {
        "utterance": "Brian Pogue: There you go. ",
        "annotations": {
            "acknowledge contribution": "Brian Pogue is acknowledging an action taken by someone else, likely Shwetadwip Chowdhury, in a minimal way."
        }
    },
    {
        "utterance": "Shwetadwip Chowdhury: Um. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Arnold Hayer: With increasing with increasing complexity also the uh the ability or the opportunity to measure subcellular properties will decrease, I guess. ",
        "annotations": {
            "develop idea": "This code applies because Arnold Hayer's utterance expands on the existing ideas about complexity by providing a specific relationship between complexity and the ability to measure subcellular properties."
        }
    },
    {
        "utterance": "Arnold Hayer: In a simple transparent system you might be able to monitor like a few different parameters, but uh in a very complex system you might just be able to track the movement of cells and that's all. ",
        "annotations": {
            "develop idea": "The utterance expands on an existing idea by explaining the relationship between system complexity and the ability to monitor parameters.",
            "signal expertise": "Arnold Hayer is sharing his perspective on a specific topic, indicating his expertise or understanding in the area."
        }
    },
    {
        "utterance": "Shwetadwip Chowdhury: Um, yeah, sorry, can you repeat that? ",
        "annotations": {
            "ask question": "The speaker is requesting clarification or repetition of a prior statement, which is a clear example of asking a question."
        }
    },
    {
        "utterance": "Arnold Hayer: No, I just meant uh because you said it task gets harder as you start moving to more complex cell systems, also if you you know, you might find a sweet spot where you can make really interesting discoveries by by being able and um to to track the cells and in addition to the just tracking their movement, you might be able to monitor intracellular activities at the same time or some other properties. ",
        "annotations": {
            "develop idea": "The speaker is expanding on a previous idea about the challenges and opportunities of working with complex cell systems, providing more insight into why tasks get harder but also suggesting potential benefits."
        }
    },
    {
        "utterance": "Shwetadwip Chowdhury: So how do we find that sweet spot? ",
        "annotations": {
            "ask question": "The speaker is requesting information or clarification on how to find the 'sweet spot,' which was mentioned in previous utterances."
        }
    },
    {
        "utterance": "Arnold Hayer: Pushing I don't know. That's the question, right? ",
        "annotations": {
            "identify gap": "The speaker explicitly recognizes a lack of knowledge by saying 'Pushing I don't know'.",
            "ask question": "The speaker seeks confirmation or clarification by asking 'That's the question, right?'"
        }
    },
    {
        "utterance": "Arnold Hayer: Well, I think finding the ideal find finding a transparent uh model and uh finding good reporters and uh and uh a good a gentle a gentle way of of imaging the system. ",
        "annotations": {
            "propose new idea": "The utterance introduces a new approach or suggestions for finding a solution, specifically mentioning finding a transparent model, good reporters, and a gentle way of imaging the system."
        }
    },
    {
        "utterance": "Brian Pogue: Um, I think Arnold was heading down the route of um. ",
        "annotations": {
            "acknowledge contribution": "Brian Pogue is verbally recognizing Arnold Hayer's input by attempting to revisit or build upon his point."
        }
    },
    {
        "utterance": "Mark Selimyer: Finding good three uh good three dimensional system because we're pretty good at two dimensional right now, but like finding a good three dimensional system to look at cell movements is maybe a good interim step before getting to to animals. ",
        "annotations": {
            "develop idea": "The speaker expands on existing ideas by suggesting a more specific approach (moving from 2D to 3D systems) as an intermediate step before moving to animal studies.",
            "offer feedback": "The utterance provides a specific suggestion for a way forward, which can be considered as offering feedback on how to proceed with the research.",
            "clarify goal": "The utterance implicitly discusses the goal of finding appropriate systems for studying cell movements, by suggesting a step forward from 2D to 3D systems."
        }
    },
    {
        "utterance": "Ping Wang: We talk talk a lot about the single cell imaging. Um, probably we should add that. Yeah, I mean. ",
        "annotations": {
            "develop idea": "The speaker suggests adding single-cell imaging to a list or discussion, building upon previous ideas.",
            "supportive response": "The utterance expresses a positive and supportive contribution to the discussion by suggesting an addition."
        }
    },
    {
        "utterance": "Mark Selimyer: Ping doesn't think it's a good idea. ",
        "annotations": {
            "critical response": "Mark Selimyer is providing a negative evaluation of an idea by referencing Ping's opinion that it's not a good idea."
        }
    },
    {
        "utterance": "Mark Selimyer: Ha ha ha. ",
        "annotations": {
            "express humor": "The speaker is making a joke, as indicated by the laughter expression 'Ha ha ha.'"
        }
    },
    {
        "utterance": "Ping Wang: No, no, no. I I think it's a brilliant idea. I like the like a push the push the technology. I mean, uh hard I mean to to help help the people like me for the application. I just I just want to have like a more justification. What are you going to do for the single cell imaging? I really like this. ",
        "annotations": {
            "supportive response": "Ping Wang expresses strong agreement and appreciation for Mark Selimyer's idea, indicating a positive evaluation.",
            "ask question": "Ping Wang requests more justification for the single-cell imaging aspect, explicitly asking for more information."
        }
    },
    {
        "utterance": "Mark Selimyer: No, I I I tend to agree with you. So I was throwing you under the bus there. But you know, it's generally populations of cells that we care most about, especially like therapeutically or you know, I I actually actually let me take it back. Let me take it back. So it could be that single cell is super important for something like development, you know, developmental biology, sort of what Crystal studies. ",
        "annotations": {
            "supportive response": "The speaker expresses agreement with a previous statement.",
            "develop idea": "The speaker expands on the discussion by highlighting the importance of populations of cells and the potential significance of single-cell imaging in developmental biology.",
            "acknowledge contribution": "The speaker references Crystal's area of expertise, acknowledging her contribution."
        }
    },
    {
        "utterance": "Mark Selimyer: But then maybe on like the therapeutic side it's more like, well, you put in 50 million car T cells and you just want to know where they go and you need to have some. ",
        "annotations": {
            "develop idea": "Mark Selimyer is expanding on previous discussions about cell tracking by providing a specific example related to therapeutic applications."
        }
    },
    {
        "utterance": "Ping Wang: I can come up one application I can come up with I'm not sure if that's that's feasible. Like for the detecting the what does the static cells. You can generate something like um pad reporter genes and detect the single cells uh detached from the primary lesion and that's a good application for the for the like early detection. That's very critical for the cancer. ",
        "annotations": {
            "propose new idea": "The speaker introduces a new application for detecting static cells using pad reporter genes for early cancer detection.",
            "develop idea": "The speaker's suggestion builds upon previous discussions, potentially expanding the scope of applications for the technology/method being discussed."
        }
    },
    {
        "utterance": "Mark Selimyer: So would it be safe to say that single cell is. ",
        "annotations": {
            "ask question": "The speaker is requesting information or clarification on the implications or status of 'single cell'."
        }
    },
    {
        "utterance": "Mark Selimyer: Helpful to determine, you know, underlying biology and that population movements may be more important for understanding therapies. ",
        "annotations": {
            "develop idea": "The utterance expands on previous ideas discussed about single-cell imaging and its applications.",
            "summarize conversation": "The utterance summarizes a part of the conversation, highlighting the importance of single-cell imaging for understanding biology and therapies."
        }
    },
    {
        "utterance": "Mark Selimyer: Maybe. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Ping Wang: Yeah. ",
        "annotations": {
            "None": "The utterance is a brief acknowledgment without adding new content or explicitly fitting into another category."
        }
    },
    {
        "utterance": "Shwetadwip Chowdhury: All right. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Crystal Rogers- UC Davis: mechanism in vivo. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Shwetadwip Chowdhury: Um yeah, we also talked about I liked the conversation about iron oxide particles. I personally don't um have any experience with that, but I thought that was a really nice contrast agent as well as the micro bubbles for ultrasound. ",
        "annotations": {
            "summarize conversation": "The speaker is referring back to and summarizing previous discussions about iron oxide particles and microbubbles for ultrasound.",
            "develop idea": "The speaker is expanding on previous ideas by discussing the potential of iron oxide particles and microbubbles."
        }
    },
    {
        "utterance": "Brad Smith: Well that seemed to be part of the the two paradigms here. One was that you would have to label exogenous cells and then you introduce them and then you track them and so then the question becomes what's the best label and you've just talked of a couple and then the that that paradigm changes to one where you're now presumably adding a contrast agent that's going to go and find a certain cell population and then stick to it or maybe longitudinally lay, you know, keep redosing all the time. There seem to be two general strategies. Each have their own particular technical challenges. ",
        "annotations": {
            "develop idea": "Brad is expanding on existing ideas by discussing two paradigms and their challenges.",
            "offer feedback": "Brad provides an analysis that can be seen as feedback on the approaches discussed.",
            "summarize conversation": "Brad summarizes the discussion into two paradigms."
        }
    },
    {
        "utterance": "Brian Pogue: And yeah, Mark, you you were talking about biologically altering cells so that you could image them. And I presume that is ex vivo and then introduced in vivo. You know. ",
        "annotations": {
            "develop idea": "Brian is expanding on Mark's idea by specifying the process (ex vivo alteration and in vivo introduction).",
            "ask question": "The utterance seeks confirmation or agreement with 'You know'."
        }
    },
    {
        "utterance": "Shwetadwip Chowdhury: Um okay, is this uh ",
        "annotations": {
            "ask question": "The speaker is seeking clarification or confirmation about something previously discussed, as indicated by 'is this uh'."
        }
    },
    {
        "utterance": "Ping Wang: I I have one um one point I'm not sure. I mean, if we should add I I think probably theranostics as I said um label the cells using the reporter gene to say the cells. That's one one um one thing um um I mean, probably we should also uh pay some attention on the uh theranostic like protect the cells or control the cells function after you put the cells in for the transplantation. Um I don't know. I have idea um because of this uh COVID-19 uh vaccine, uh we had we had work on the SRI uh SRA um conjugation to the nanoparticles to uh silence the harmful genes for the cells related to apoptosis or related to the new rejection. Um I was fascinated uh to read the papers and I I also I got the vaccine uh to to know uh the the nanoparticle can deliver the RNA to to your immune cells. So um I mean if we can um work on some like imaging to see the um how this RNA uh works because because um because um before this uh COVID-19 before this uh vaccine uh it's hard for me to understand how you can deliver um like RNA to the cells and the cells going to translate to the protein and this protein can can be recognized by um immune cells. ",
        "annotations": {
            "propose new idea": "The speaker introduces new ideas about using theranostics, specifically labeling cells with reporter genes, and discusses potential applications.",
            "ask question": "The speaker expresses uncertainty and asks for input or clarification on the approach and feasibility of using theranostics and imaging.",
            "clarify goal": "The speaker aims to understand and suggest approaches for using theranostics and imaging in the context of cell transplantation and RNA delivery."
        }
    },
    {
        "utterance": "Shwetadwip Chowdhury: Where should I put that, Ping? ",
        "annotations": {
            "ask question": "The speaker is requesting information or clarification from Ping on where to put something, indicating a question being asked."
        }
    },
    {
        "utterance": "Ping Wang: I would suggest ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Shwetadwip Chowdhury: So we're like fighting for space here, so what would be the best place to put it? ",
        "annotations": {
            "ask question": "The speaker is requesting information or suggestions from others on where to place something, indicating a question being asked."
        }
    },
    {
        "utterance": "Ping Wang: I would suggest have like another one like theranostics imaging. ",
        "annotations": {
            "propose new idea": "The speaker is introducing a new suggestion for organizing or adding to their discussion, specifically proposing to have another category like 'theranostics imaging'."
        }
    },
    {
        "utterance": "Shwetadwip Chowdhury: Okay. ",
        "annotations": {
            "None": "No relevant code applies to this utterance as it is a minimal acknowledgment without additional content."
        }
    },
    {
        "utterance": "Shwetadwip Chowdhury: Theranostics. ",
        "annotations": {
            "None": "The utterance simply references a term previously mentioned in the conversation without adding new content or explicitly fitting into any of the defined codes."
        }
    },
    {
        "utterance": "Shwetadwip Chowdhury: Um ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Shwetadwip Chowdhury: How do you spell that? I don't I I haven't heard that word before. ",
        "annotations": {
            "ask question": "The speaker is explicitly asking for information about the spelling of a word.",
            "identify gap": "The speaker mentions that he hasn't heard the word before, indicating a lack of knowledge."
        }
    },
    {
        "utterance": "Ping Wang: Therapy. Therapy plus diagnose and then ",
        "annotations": {
            "propose new idea": "The speaker is introducing a new concept or term 'Therapy plus diagnose', which suggests a combination of therapeutic and diagnostic approaches."
        }
    },
    {
        "utterance": "Ping Wang: Theranostics. ",
        "annotations": {
            "acknowledge contribution": "The speaker is acknowledging or referencing a term 'Theranostics' that has been previously discussed in the conversation."
        }
    },
    {
        "utterance": "Brad Smith: Yeah. ",
        "annotations": {
            "supportive response": "Expressing agreement with a prior statement."
        }
    },
    {
        "utterance": "Ping Wang: I can uh I know I have ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Brad Smith: Okay. ",
        "annotations": {
            "Acknowledge contribution": "The speaker is acknowledging a prior statement or suggestion made by another group member."
        }
    },
    {
        "utterance": "Brad Smith: Yeah. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Brad Smith: Okay. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Brad Smith: Okay. ",
        "annotations": {
            "Supportive response": "The utterance 'Okay.' expresses agreement or validation of a prior statement, making it a supportive response.",
            "Acknowledge contribution": "The utterance 'Okay.' also serves to acknowledge a contribution from another group member, even if minimally."
        }
    },
    {
        "utterance": "Shwetadwip Chowdhury: Okay. ",
        "annotations": {
            "acknowledge contribution": "The speaker acknowledges a prior suggestion or statement."
        }
    },
    {
        "utterance": "Brad Smith: Okay. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Shwetadwip Chowdhury: Okay. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Brad Smith: Okay. ",
        "annotations": {
            "None": "No relevant code applies to this utterance as it is too brief and only serves as an acknowledgment."
        }
    },
    {
        "utterance": "Shwetadwip Chowdhury: Okay. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Brad Smith: Okay. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Shwetadwip Chowdhury: Okay. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Brad Smith: Okay. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Shwetadwip Chowdhury: Okay. ",
        "annotations": {
            "supportive response": "The utterance 'Okay.' is a minimal supportive response, expressing agreement or acknowledgment to a previous statement."
        }
    },
    {
        "utterance": "Brad Smith: Okay. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Shwetadwip Chowdhury: Okay. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Brad Smith: Okay. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Shwetadwip Chowdhury: Okay. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Brad Smith: Okay. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Shwetadwip Chowdhury: Okay. ",
        "annotations": {
            "None": "No relevant code applies to this utterance as it is a brief acknowledgment without adding new content."
        }
    },
    {
        "utterance": "Brad Smith: Okay. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Shwetadwip Chowdhury: Okay. ",
        "annotations": {
            "None": "No relevant code applies to this utterance as it only contains a minimal acknowledgment."
        }
    },
    {
        "utterance": "Brad Smith: Okay. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Shwetadwip Chowdhury: Okay. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Brad Smith: Okay. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Shwetadwip Chowdhury: Okay. ",
        "annotations": {
            "None": "The utterance 'Okay.' is a very brief acknowledgment that does not add significant content to the conversation."
        }
    },
    {
        "utterance": "Brad Smith: Okay. ",
        "annotations": {
            "None": "No relevant code applies to this utterance"
        }
    },
    {
        "utterance": "Mark Selimyer (UPenn): Not too much. There's, yeah, there are things like FDG that measures your metabolism, but you're looking at the body's own metabolism, um, and up regulated in immune cells. So there's a group down at Johns Hopkins, um, Sanjay Jane's group has been working on this and they've got some, um, labeled sorbitol for pet imaging, which is kind of cool because we don't take, we don't use sorbitol as a carbon source, but bugs do. Um, we're using an antibiotic, uh, trimethoprim to image bacteria themselves. Other people are using D amino acids. So there's a whole, you know, like chemistry world that's out there trying to develop probes specific for your question, um, you know, Brad about how to image pathology, um, using these probe development approaches. ",
        "annotations": {
            "develop idea": "The speaker is expanding on the idea of imaging pathology by mentioning specific approaches and examples.",
            "signal expertise": "The speaker is sharing knowledge from their field, indicating expertise.",
            "express humor": "The speaker makes a lighthearted comment ('which is kind of cool')."
        }
    },
    {
        "utterance": "Brian Pogue - Dartmouth: There's a lot of focus on immune probes, but it seems like metabolic probes are a whole lot easier because they wind up, the concentrations wind up being orders of magnitude higher. ",
        "annotations": {
            "develop idea": "Brian Pogue is expanding on the concept of probes by comparing immune and metabolic probes.",
            "offer feedback": "Brian Pogue is providing a perspective on the relative ease of use of metabolic probes compared to immune probes."
        }
    },
    {
        "utterance": "Brad Smith, Notre Dame: The problem with metabolic probes is that the cells have to be metabolically active. So you know, in the bacteria, once you get biofilms and the things calm down, then then really they're not taking up much stuff and so they get harder metabolic probes struggle that way then. ",
        "annotations": {
            "develop idea": "This utterance expands on an existing idea (metabolic probes) by providing more information on their functioning and a specific challenge related to their use."
        }
    },
    {
        "utterance": "Brian Pogue - Dartmouth: I think there's some cool research too. ",
        "annotations": {
            "supportive response": "The speaker is expressing a positive sentiment towards certain research, indicating agreement or interest."
        }
    },
    {
        "utterance": "Mark Selimyer (UPenn): Brian from, you know, Anna Woo's group out at City of Hope and and you probably know her and looking at immune cells, cell surface markers, right? So how do you track CD8 T cells and them wandering around and getting into tumors or not with immunotherapies and things like that. ",
        "annotations": {
            "ask question": "The speaker asks for information on how to track CD8 T cells, indicating a request for knowledge or expertise.",
            "encourage participation": "The question posed invites others to contribute their thoughts or expertise, encouraging participation."
        }
    },
    {
        "utterance": "Brian Pogue - Dartmouth: Yeah, the challenge I always talk about is is immunology exists at the nanomolar level really and and and metabolism exists at the micromolar level and it's it's a whole lot easier to image micromolars than it is to image nanomolars. ",
        "annotations": {
            "develop idea": "The speaker expands on existing ideas by discussing the challenges of imaging at different concentration levels in immunology and metabolism.",
            "identify gap": "The speaker highlights a challenge in imaging, specifically the difficulty of imaging at the nanomolar level compared to the micromolar level."
        }
    },
    {
        "utterance": "Mark Selimyer (UPenn): I think they're going after, you know, cell specific markers that are on the surface using things like immuno pet probes where you've got an antibody that's specific for that. ",
        "annotations": {
            "develop idea": "The speaker is expanding on an existing idea by explaining how immuno PET probes work and their application in targeting cell-specific markers.",
            "signal expertise": "The speaker demonstrates his knowledge and expertise in the field, specifically in immuno PET probes and their applications."
        }
    }
]